Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jul 2;16(1):101.
doi: 10.1186/s12916-018-1086-7.

Recurrence quantification analysis of resting state EEG signals in autism spectrum disorder - a systematic methodological exploration of technical and demographic confounders in the search for biomarkers

Affiliations

Recurrence quantification analysis of resting state EEG signals in autism spectrum disorder - a systematic methodological exploration of technical and demographic confounders in the search for biomarkers

T Heunis et al. BMC Med. .

Abstract

Background: Autism spectrum disorder (ASD) is a neurodevelopmental disorder with a worldwide prevalence of 1-2%. In low-resource environments, in particular, early identification and diagnosis is a significant challenge. Therefore, there is a great demand for 'language-free, culturally fair' low-cost screening tools for ASD that do not require highly trained professionals. Electroencephalography (EEG) has seen growing interest as an investigational tool for biomarker development in ASD and neurodevelopmental disorders. One of the key challenges is the identification of appropriate multivariate, next-generation analytical methodologies that can characterise the complex, nonlinear dynamics of neural networks in the brain, mindful of technical and demographic confounders that may influence biomarker findings. The aim of this study was to evaluate the robustness of recurrence quantification analysis (RQA) as a potential biomarker for ASD using a systematic methodological exploration of a range of potential technical and demographic confounders.

Methods: RQA feature extraction was performed on continuous 5-second segments of resting state EEG (rsEEG) data and linear and nonlinear classifiers were tested. Data analysis progressed from a full sample of 16 ASD and 46 typically developing (TD) individuals (age 0-18 years, 4802 EEG segments), to a subsample of 16 ASD and 19 TD children (age 0-6 years, 1874 segments), to an age-matched sample of 7 ASD and 7 TD children (age 2-6 years, 666 segments) to prevent sample bias and to avoid misinterpretation of the classification results attributable to technical and demographic confounders. A clinical scenario of diagnosing an unseen subject was simulated using a leave-one-subject-out classification approach.

Results: In the age-matched sample, leave-one-subject-out classification with a nonlinear support vector machine classifier showed 92.9% accuracy, 100% sensitivity and 85.7% specificity in differentiating ASD from TD. Age, sex, intellectual ability and the number of training and test segments per group were identified as possible demographic and technical confounders. Consistent repeatability, i.e. the correct identification of all segments per subject, was found to be a challenge.

Conclusions: RQA of rsEEG was an accurate classifier of ASD in an age-matched sample, suggesting the potential of this approach for global screening in ASD. However, this study also showed experimentally how a range of technical challenges and demographic confounders can skew results, and highlights the importance of probing for these in future studies. We recommend validation of this methodology in a large and well-matched sample of infants and children, preferably in a low- and middle-income setting.

Keywords: Autism spectrum disorder; RQA; Recurrence quantification analysis; Resting state electroencephalography.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

De-identified rsEEG data were obtained from Boston Children’s Hospital, Harvard Medical School, Boston, USA. These data were a clinical collection of EEG’s for a protocol entitled, “Risk factors for poor outcome in tuberous sclerosis”. IRB/ethics approval at the host institute included a ‘waiver of consent’ to allow sharing of data with collaborators without seeking further consent from participants. Participants therefore consented to ‘de-identified’ data being used. Data collection and analysis for this study had already been completed, and results were published by Peters et al. [30]. Ethics approval for the secondary analysis of this data was obtained from both Tygerberg Health Research Ethics Committee (reference # S14/06/128) and the University of Cape Town Human Research Ethics Committee (reference # 865/2014).

Competing interests

CA, JMP, SSJ, MS and PJdV report no conflicts of interest in relation to the work presented here. TH was the developer of the RQA biomarker method [23]. However, she does not have any financial conflicts of interest in relation to the method, which was published in an open-access, peer-reviewed publication [23].

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
EEG signal processing methodology
Fig. 2
Fig. 2
Progress loop of sample population analysis
Fig. 3
Fig. 3
Classification accuracy of different feature sets for full sample cross-validation run 1
Fig. 4
Fig. 4
Classification accuracy of different feature sets for subsample cross-validation run 1
Fig. 5
Fig. 5
Classification accuracy of different feature sets for age-matched sample cross-validation run 1
Fig. 6
Fig. 6
Generalisation performance for age-matched sample cross-validation run 1
Fig. 7
Fig. 7
Cross-validation performance for the (a) linear discriminant analysis (LDA), (b) multilayer layer perceptron (MLP) and (c) support vector machine (SVM) classifiers
Fig. 8
Fig. 8
Feature shuffle analysis of feature set 1 for age-matched sample cross-validation run 1
Fig. 9
Fig. 9
Optimal feature subset identification for age-matched sample cross-validation run 1
Fig. 10
Fig. 10
Visualisation of the feature space in a 2D principal component (PC) subspace, (a) training features and (b) test features for age-matched sample cross-validation run 1
Fig. 11
Fig. 11
Visualisation of the feature space in a 3D principal component (PC) subspace, (a) training features and (b) test features for age-matched sample cross-validation run 1
Fig. 12
Fig. 12
Repeatability analysis for the (a) linear discriminant analysis (LDA), (b) multilayer layer perceptron (MLP) and (c) support vector machine (SVM) classifiers for age-matched sample cross-validation run 1
Fig. 13
Fig. 13
Generalisation performance for age-matched sample leave-one-subject-out analysis
Fig. 14
Fig. 14
Repeatability analysis for the (a) linear discriminant analysis (LDA), (b) multilayer layer perceptron (MLP) and (c) support vector machine (SVM) classifiers for age-matched sample leave-one-subject-out analysis

References

    1. Walsh P, Elsabbagh M, Bolton P, Singh I. In search of biomarkers for autism: scientific, social and ethical challenges. Nat Rev Neurosci. 2011;12:603–612. doi: 10.1038/nrn3113. - DOI - PubMed
    1. Jeste SS, Frohlich J, Loo SK. Electrophysiological biomarkers of diagnosis and outcome in neurodevelopmental disorders. Curr Opin Neurol. 2015;28:110–116. doi: 10.1097/WCO.0000000000000181. - DOI - PMC - PubMed
    1. Heunis T, Aldrich C, de Vries PJ. Recent advances in resting-state electroencephalography biomarkers for autism Spectrum disorder-a review of methodological and clinical challenges. Pediatr Neurol. 2016;61:28–37. doi: 10.1016/j.pediatrneurol.2016.03.010. - DOI - PubMed
    1. Baird G, Simonoff E, Pickles A, Chandler S, Loucas T, Meldrum D, Charman T. Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the special needs and autism project (SNAP) Lancet. 2006;368:210–215. doi: 10.1016/S0140-6736(06)69041-7. - DOI - PubMed
    1. Kim YS, Leventhal BL, Koh Y, Fembonne E, Laska E, Lim E, Cheon K, Kim S, Kim Y, Lee H, et al. Prevalence of autism spectrum disorders in a total population sample. Am J Psychiatr. 2011;168:904–912. doi: 10.1176/appi.ajp.2011.10101532. - DOI - PubMed

Publication types